Pharmaceuticals

Advertisement
US Health Secretary Robert F. Kennedy Jr and President Donald Trump.

Trump’s tariffs and anti-vaxxer clash with Australia’s $130b health giant

CSL is battling the US president’s threat against big pharma and the vaccine scepticism of his health tsar, but that’s not why its shares plunged on Tuesday.

  • Colin Kruger

Latest

Weight-loss jabs such as Ozempic have soared in popularity.

Ozempic maker cuts price of wonder drug in half in US

Novo Nordisk is slashing the cost of Ozempic for cash-paying patients after the diabetes shot became the poster child for high US drug prices.

  • Madison Muller
The company bewildered analysts in May when it abruptly said it would replace CEO Lars Fruergaard Jorgensen.

‘Absolutely dire’: How it all went wrong for Ozempic’s maker after creating a wonder drug

For years, there was no stopping the Danish drugmaker behind Ozempic. Then, suddenly, its fortunes took a turn.

  • Eshe Nelson
The Trump administration has hit out at other countries offering cheaper drug prices than the US.

‘A very big threat’: Australia defends PBS as Trump flags 250% tariffs on medicines

Health Minister Mark Butler will get advice within days on speeding up medicine approvals – one of the key issues that US pharmaceutical giants have raised with Donald Trump.

  • Natassia Chrysanthos
US President Donald Trump in the White House this week.

Trump takes aim at ‘foreign freeloading nations’ over drug prices in new threat to PBS

As the world awaits new US tariffs, the president has ordered American pharmaceutical firms to “negotiate harder” with other countries and return those increased profits to the US.

  • Michael Koziol
Weight-loss jabs such as Ozempic have soared in popularity.

Ozempic drugmaker just became a victim of its own success

For blame, look no further than pirates and the president (Trump, of course).

  • Elizabeth Knight
Advertisement
At its peak last year, Novo Nordisk was worth as much as $US615 billion, but its shares have plunged on investor concerns about the company’s experimental drug pipeline and its ability to navigate challenges in the US market.

Ozempic maker takes $107 billion hit as alarm bells ring louder

The Danish drugmaker started the obesity drug race. Now it is losing it.

  • Jacob Gronholt-Pedersen, Stine Jacobsen and Maggie Fick
A new research partnership aims at making medicine you can eat.

French fries that work like Ozempic: The push to make medicine you can eat

Peanuts instead of Panadol and a salad that can kill your appetite could be the results of a new Sydney research project.

  • Angus Dalton
Plasma-ripping return of a Varda capsule at Mach 25.

Drugs in space: the adventure inspired by ‘Breaking Bad’

Varda Industries is aiming to create a viable industry manufacturing drugs in space, where the lack of gravity unlocks new possibilities. And Australia is well positioned to play a part.

  • Chris Zappone
Markets have been in wait-and-see mode on Trump’s trade proclamations, given he has changed rates and deadlines multiple times since he announced country-by-country tariffs on April 2.

Labor and Coalition in lockstep as Trump threatens to pull pharma tariffs forward

Donald Trump has announced plans to impose sky-high tariffs on pharmaceuticals, Australia’s third-largest export to the US.

  • Nick Newling